Description
UPTRAVI 1600MCG MODIFICATION TO DECREASE QUANTITY
Base award description: UPTRAVI 1600MCG PRICE PER NAC CONTRACT 36F79719D0142
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2024-01-11+$196,208= $196,208
- Mod P000012025-01-13-$30,186= $166,022
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2024-01-11 | +$196,208 | $196,208 | UPTRAVI 1600MCG PRICE PER NAC CONTRACT 36F79719D0142 |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2025-01-13 | −$30,186 | $166,022 | UPTRAVI 1600MCG MODIFICATION TO DECREASE QUANTITY |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI LERPSGUE3528)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25226P0445 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $349,099 | FY2026 |
| 36C25926P0120 | NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS | $11,198 | FY2026 |
| 36C25925P1097 | NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS | $11,198 | FY2025 |
| 36C24225P1342 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $17,490 | FY2025 |
| 36C24225P1200 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $10,122 | FY2025 |
| 36C26025P0979 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $13,364 | FY2025 |
Other recipients under 6505 from 246-NETWORK CONTRACTING OFFICE 6 (36C246) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24626N1034 | PARTNER THERAPEUTICS, INC. | 246-NETWORK CONTRACTING OFFICE 6 (36C246) | $72,362 | FY2026 |
| 36C24626A0027 | PROGENICS PHARMACEUTICALS INC | 246-NETWORK CONTRACTING OFFICE 6 (36C246) | $0 | FY2026 |
| 36C24626N0890 | PROGENICS PHARMACEUTICALS INC | 246-NETWORK CONTRACTING OFFICE 6 (36C246) | $1,212,530 | FY2026 |
| 36C24626N0782 | PARTNER THERAPEUTICS, INC. | 246-NETWORK CONTRACTING OFFICE 6 (36C246) | $72,563 | FY2026 |
| 36C24626N0690 | PARTNER THERAPEUTICS, INC. | 246-NETWORK CONTRACTING OFFICE 6 (36C246) | $54,422 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24624P0518_3600_-NONE-_-NONE- · retrieved 2026-09-26.